PER
Click for more information
4.94% 8.5¢ percheron therapeutics limited

FDA approves Sareptas Srp901 for the whole population, page-23

  1. Insulsa
    76 Posts.
    lightbulb Created with Sketch. 25
    clock Created with Sketch.
    22/06/24
    23:01
    Post #: 74442217
    I am really puzzled and I would like to know if someone can help me to clarify. AKKI when post something referring PER one way or another is always negative never post anything good about PER and no one among PER share holders has ever tried to contradict and/or at least ask to explain why this continuous negativity.
    Then today made a couple of post about Sarepta FDA approval and he gets great amount of thumbs up.
    What did I miss????
    PER Price at posting: 8.7¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 9  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NIM Nimy extends sulphide targets at Mons with new anomalies identified
right-arrow Created with Sketch.
LYC Lynas eyes first dysprosium, terbium HREE production in CY25
right-arrow Created with Sketch.
PDN Paladin flags up to 4.5Mlbs of uranium production in FY25 guidance
right-arrow Created with Sketch.
NEWS Tenant turnover: Reducing costs and revenue-loss
right-arrow Created with Sketch.
RMS Ramelius boosts WA gold portfolio with stake in Spartan
right-arrow Created with Sketch.
NEWS Microcap Wrap: 5 explorers with news out today
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.5¢ 		Change
0.004(4.94%) 		Mkt cap ! $76.63M
Open High Low Value Volume
8.1¢ 8.5¢ 8.1¢ $46.54K 563.7K

Buyers (Bids)

No. Vol. Price($)
2 164616 8.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.5¢ 100110 1
View Market Depth
Last trade - 15.55pm 28/06/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.